CD4 and neoplasm: For example, CCL18 has been shown to promote the proliferation of oral squamous cell carcinoma cells and recruit naive CD4+ T cells into the tumor microenvironment, leading to their differentiation into regulatory T cells that contribute to tumor immune evasion (54, 55).